Insmed INSM
NASDAQ INSM
$119.37 -0.12 (-0.10%)
As of: Nov 11, 2026 · 11:04 AM EST

Insmed (INSM) Net Equity Issued and Repurchased (2012 - 2026)

Updated

Insmed's Net Equity Issued and Repurchased was $28.01 million in Q2 2026, down 96.7% from $860.5 million a year earlier and down 7.6% from the prior quarter.

Analysis

Insmed (INSM) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Insmed's Net Equity Issued and Repurchased was $127.11 million through Jun 30, 2026, down 90.2% year-over-year; for FY2025, it came in at $959 million, down 19.9% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 28.7% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $1.2 billion in FY2024 (+600.7%), $170.87 million in FY2023 (-45.2%), $311.66 million in FY2022 (+6.8%) and $291.92 million in FY2021 (+7.3%).
  • The Q2 2026 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in four of the last seven quarters, with growth averaging 74.4%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2025 (growth of 633.1%); the worst was Q2 2022 (a decline of 97.7%).
  • Per Business Quant data, INSM's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $30.31 million (Q1 2026), $34.64 million (Q4 2025) and $34.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Insmed 26.21 Bn 21.25 Bn 446.21 Mn 24.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 24.48 Mn
Jun 30, 2026 28.01 Mn
Mar 31, 2026 30.31 Mn
Dec 31, 2025 34.64 Mn
Sep 30, 2025 34.16 Mn
Jun 30, 2025 860.50 Mn
Mar 31, 2025 29.70 Mn
Dec 31, 2024 13.73 Mn
Sep 30, 2024 397.86 Mn
Jun 30, 2024 781.73 Mn
Mar 31, 2024 4.05 Mn
Dec 31, 2023 122.10 Mn
Sep 30, 2023 2.34 Mn
Jun 30, 2023 45.30 Mn
Mar 31, 2023 1.14 Mn
Dec 31, 2022 260.94 Mn
Sep 30, 2022 37.45 Mn
Jun 30, 2022 6.45 Mn
Mar 31, 2022 6.82 Mn
Dec 31, 2021 6.02 Mn
API Access

Insmed Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=INSM&period=max&api_key=YOUR_API_KEY